Logo

Cytogen's AxCell Unit in Partnership with InforMax

Aug 27, 1999
Premium

PRINCETON, NJ--AxCell Biosciences, the wholly owned subsidiary of Cytogen, signed a letter of intent with InforMax to market AxCell's proteomics database as part of an enterprise bioinformatics solution to pharmaceutical, biotechnology, and agricultural industries. The multi-year agreement provides for technology development by InforMax to link AxCell's database to InforMax's a molecular biology and genetics product, Software Solution for Bio-Medicine. AxCell's proprietary technology identifies protein-protein interactions to create its Inter-Functional Proteomic database. Through their collaboration, the two companies said they would link the database with an intuitive user interface in an enterprise system design to allow customers to utilize the information with other existing data and algorithms.

Filed under

Informatics
Breaking News
The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.